SIPA1L3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.621000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.559400E-01
Normal-vs-Stage2
7.098800E-01
Normal-vs-Stage3
5.018600E-01
Normal-vs-Stage4
3.294200E-01
Stage1-vs-Stage2
3.754200E-01
Stage1-vs-Stage3
3.188200E-01
Stage1-vs-Stage4
4.224200E-01
Stage2-vs-Stage3
2.028400E-01
Stage2-vs-Stage4
3.827600E-01
Stage3-vs-Stage4
1.397580E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.634400E-01
Normal-vs-AfricanAmerican
7.597600E-01
Normal-vs-Asian
6.423000E-01
Caucasian-vs-AfricanAmerican
8.525400E-01
Caucasian-vs-Asian
5.683400E-01
AfricanAmerican-vs-Asian
9.935400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.614200E-01
Normal-vs-Female
7.889000E-01
Male-vs-Female
6.709600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.850000E-01
Normal-vs-Age(41-60Yrs)
4.967000E-01
Normal-vs-Age(61-80Yrs)
7.756600E-01
Normal-vs-Age(81-100Yrs)
9.409400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.992600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.936000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.834400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.326800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.611160E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.129400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.920000E-01
Normal-vs-Daily Drinker
6.040400E-01
Normal-vs-Weekly Drinker
7.938600E-01
Normal-vs-Occasional Drinker
5.844600E-01
Normal-vs-Social Drinker
5.174800E-01
Non Drinker-vs-Daily Drinker
5.991000E-01
Non Drinker-vs-Weekly Drinker
7.921200E-01
Non Drinker-vs-Occasional Drinker
9.560800E-01
Non Drinker-vs-Social Drinker
9.452400E-01
Daily Drinker-vs-Weekly Drinker
5.311800E-01
Daily Drinker-vs-Occasional Drinker
5.646000E-01
Daily Drinker-vs-Social Drinker
6.425400E-01
Weekly Drinker-vs-Occasional Drinker
8.058600E-01
Weekly Drinker-vs-Social Drinker
7.267800E-01
Occasional Drinker-vs-Social Drinker
8.796800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.119400E-01
Normal-vs-Grade 2
4.104500E-02
Normal-vs-Grade 3
2.186500E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.878200E-01
Grade 1-vs-Grade 3
3.633000E-01
Grade 1-vs-Grade 4
5.119400E-01
Grade 2-vs-Grade 3
3.992200E-01
Grade 2-vs-Grade 4
4.104500E-02
Grade 3-vs-Grade 4
2.186500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.798400E-01
Normal-vs-NonDiabetic
7.115200E-01
Diabetic-vs-NonDiabetic
5.979600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.769200E-01
Normal-vs-NoPancreatitis
7.650000E-01
Pancreatitis-vs-NoPancreatitis
8.926200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.674400E-01
Normal-vs-N1
7.098800E-01
N0-vs-N1
9.062200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.788000E-01
Normal-vs-TP53-NonMutant
1.457560E-01
TP53-Mutant-vs-TP53-NonMutant
5.757800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
